Insight Molecular Diagnostic

Penny Stocks Biotech Stocks Healthcare Stocks

$4.05

+0.34 (+9.16%)

As of Aug 14, 2:35 PM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 7 70%

Hold 3 30%

Sell 0 0%

Price Target

Analyst Price Target +329.9% upside

Low Target $14.05

Average Target $17.41

High Target $26.42

Current Price $4.05

Current
$4.05

Target
$17.41

$14.05 $17.41 avg $26.42

Scenario Analysis

Bear Case

$14.05

246.9%

Low target

Base Case

$17.41

+329.9%

Avg target

Bull Case

$26.42

+552.3%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$8.51

-52.4% from high

52-Week Low

$2.33

+73.8% from low

Target vs 52W High

$17.41

+104.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%